Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

ERA-NET EURONANOMED III: Búsqueda de pymes especializadas sen microfluídica y anticuerpos monoclonales

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDES20161215001
Publicado:
22/12/2016
Caducidad:
22/12/2017
Resumen:
Un instituto español de biomedicina busca pymes interesadas en participar en la convocatoria ERA-NET EURONANOMED III (Proyectos europeos innovadores de investigación y desarrollo tecnológico en nanomedicina). Específicamente busca una empresa especializada en microfluídica para realizar medidas lab-on-a-chip y una segunda compañía con experiencia en preparación de anticuerpos monoclonales. El principal objetivo del proyecto es desarrollar una plataforma de kits para el diagnóstico de enfermedades neurológicas. La fecha límite para presentar las propuestas preliminares es el 16 de enero de 2017 y la fecha para presentar las propuestas completas es el 9 de junio.

Details

Tittle:
ERA-NET EURONANOMED III: seeking SMEs focusing on microfluidics and monoclonal antobodies
Summary:
A Spanish biomedical institute is seeking for SMEs to participate in ERA-NET EURONANOMED III "European Innovative Research -Y- Technological Development Projects in Nanomedicine". Two companies are sought; one specialized on microfluidics for lab-on-a-chip measurements, and another with expertise in monoclonal antibodies preparation. The main objective of the project is to develop a companion kit platform for diagnosis of neuronal diseases.
Description:
Neurodegenerative diseases, such as Parkinson´s, Alzheimer´s, and Huntington´s occur as a result of progressive loss of structure or function of neurons. Such diseases account for more that 12 Million cases worldwide. Diagnosis of is nowadays mainly made on neuropsychogical testing and confirmed by histopathologic examination. The lack of early diagnosis procedures prevents the development of therapies during the onset of the disease, which is crucial to stop or slow down neurodegeneration.

The consortium, lead by a Spanish Biomedical institute, has identified biomarkers that in combination with ultrasensitive spectroscopic techniques mediated by nanostructured materials will allow the development of diagnosis kits with several applications; early diagnosis, monitoring or companion kit.

The main objective of the 3 year duration project is to develop a companion kit platform for diagnosis of neuronal diseases. 2 targets have been already identified:

- Role 1. Industrial partner with expertise in preparation of monoclonal antibodies
Develop the antibodies necessary to detect target biomarkers and functionalize the nanostructures.

The antigens used to generate the monoclonal antibodies will prepared by chemical synthesis. The company will be in charge to develop the corresponding hybridoma and the isolation of the monoclonal antibodies.


- Role 2. Industrial partner with expertise in microfluidics

This company is expected to develop and design of the microfluidic prototype: The prototype will be the microsensor chip where the microinjection of the sample and the nanoparticles will be performed, before the spectrometric measurement is made.


The companies must be established in one of the following countries; France, Germany, Italy, Greece, Latvia, Norway, Poland, Romania or Turkey

Call Information:
ERA-NET EURONANOMED III Joint Transnational Call for Proposals (2017) for "European Innovative Research -Y- Technological Development Projects in Nanomedicine
Submission deadline for pre-proposals: 16th January 2017
Submission deadline of full proposals: 9th June 2017
Available budget for this Call: 14 Mil-Y-euro; (approx.)

http://www.euronanomed.net/joint-calls/8th-joint-call-2017-2/

Partner sought

Partner Sought:
Two companies sought; - A company specialized on microfluidics for lab-on-a-chip measurements, -A company with expertise in monoclonal antibodies preparation.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
R-Y-D Institution
Already Engaged in Trans-National Cooperation:
No

Dissemination

Restrict dissemination to specific countries:
France
Germany
Greece
Italy
Latvia
Norway
Poland
Romania
Turkey

Programme-call

Coordinator Required:
No
Deadline for Call:
16/01/2017
Project Duration:
0